Regulation of macrophage scavenger receptor (MSR) activity may be an important determinant of the extent of atherogenesis. The effect of macrophage-colony-stimulating factor (M-CSF) on this pathway was studied using a recently developed monoclonal antibody to murine MSR. M-CSF markedly and selectively increased MSR synthesis in murine macrophages: posttranslationally, the receptor appeared more stable and shifted to a predominantly surface distribution. Functionally, M-CSF enhanced modified lipoprotein uptake and increased divalent cationindependent adhesion in vitro. These results suggest a plausible mechanism whereby M-CSF production in the atheromatous plaque microenvironment could promote the recruitment and retention of mononuclear phagocytes and subsequent foam cell formation.
M
acrophages (MO) serve as the principal inflammatory . cell in the atheromatous plaque microenvironment. The macrophage scavenger receptor (MSR) mediates modified lipoprotein-cholesterol uptake and subsequent cholesteryl ester accumulation and foam cell formation (1) and the regulation of MSR expression and activity therefore represents an important determinant of the extent of atherogenesis.
M-CSF treatment in patients with hematological disease coincides with significant reductions in serum cholesterol levels. As M-CSF enhances acetyhted low-density lipoprotein (AcLDL) uptake and degradation in human monocyte-derived MO (2), the MSR pathway has been nonspecifically implicated in this observed reduction in serum cholesterol. Scavenger receptor activity is however also expressed by endothdiai, Kupffer, and liver parenchymal cells (3, 4) as well as by phorbol esterinduced fibroblasts and smooth muscle cells (5) . Molecules other than the macrophage-specific MSR may mediate these properties. Furthermore, other MO receptors such as the thrombospondin receptor (CD36) and the IgG Fc receptor (Fc'/RII-B2; CD32) are capable of mediating uptake of oxidized lipoprotein (6, 7) . Characterization of MSR regulation and expression has been hampered by the lack of specific reagents.
Both human and rabbit atherosclerotic lesions contain M-CSF mRNA and immunoreactive M-CSF (8, 9) . Vascular endothelial cells and smooth muscle cells produce M-CSF in response to a range of stimuli, including modified LDL (10) . In addition, a novel function for the MSR as an adhesion receptor was recently described (11) ; this stemmed from Cytokines were used at the final concentrations indicated. Purified recombinant human M-CSF (1,000 U/m1) from Dr. S. Aukerman (Cetus Corp., Berkeley, CA) is known to act on murine cells (12) . Purified recombinant murine GM-CSF (1,000 U/ml) was a gift from Dr. A. Bernard (Glaxo Institute for Molecular Biology, Geneva, Switzerland). Murine M-CSF reagents used were either L cell conditioned medium (15% of RPMI 1640 incubation medium) as a rich source of murine M-CSF (13) or murine M-CSF (=1,000 U/ml) as supematant from transfected insect cells obtained from Dr. J. Schreurs.
Immunoblotting and Immunoprecipitation. Cells were plated at a density of 5 x 10+/well in 35-mm tissue culture plastic dishes in KPMI plus 10% FCS and washed after 1-h incubation at 37~ Remaining adherent cells were treated with cytokines for 48 h. Metabolic labeling and immunoprecipitation was carried out as described (11) . Protein concentrations of lysates were measured using the bicinchoninic acid Protein Assay Reagent Kit (Pierce, Rockford, IL). Protein separation was by nonreducing (for immunoblotting) or reducing (for immunoprecipitation) 5-10% linear gradient SDS-PAGE. Equal amounts of total cellular protein (20 tzg) were loaded. First, antibody was diluted to 10 #g/ml followed by incubation with peroxidase-conjugated anti-rat IgG antibody (1:1,000) and detection by chemiluminescence (ECL; Amersham International, Amersham, Bucks, UK).
Call surface distribution of MSK was investigated by labeling BgPMO overnight with 100 #Ci/ml Trans3SS-label TM (ICN Biochemicals, Irvine, CA). Cells were subsequently washed and subjected to surface biotinylation using sulfo-NHS-SS-biotin (Pierce) as described (14) . Quantification of protein bands on dried gels was by Phosphorlmager and ImageQuant software analysis program (Molecular Dynamics, Inc., Sunnyvale, CA) and results expressed as a ratio of arbitrary PhosphorImager units (APUs). CellAdhesion Assays. BgPMO were cultured in R.PMI plus 10% FCS on tissue culture plastic (TCP) surfaces in the presence or absence of recombinant human M-CSF. Divalent cation-independent adhesion to TCP was assayed as described (11) .
Quantitation of AcLDL Uptake. BgPMO in 24-well TCP plates (3 x 106 cells/well) with M-CSF treatment in triplicate were exposed to 10 #g/ml AcLDL labeled with DiI (1,1'-dioctadecyl-l-3,3, 3',3'-tetramethylindocarbocyanine perchlorate) (Biogenesis, Bournemouth, UK). Uptake of DiIAcLDL was measured by flow cytometry as described (16) .
Results and Discussion
To investigate the effects of M-CSF on MSR expression and function, we treated primary murine MO with recombinant human M-CSF which is known to act on routine ceils (12) . M-CSF treatment for 48 h markedly upregulated the expression of MSR protein on immunoblot analysis (Fig. 1,  A and/3 ). Recombinant murine GM-CSF, which decreases serum cholesterol to a lesser extent when infused as an adjunct to chemotherapy (17) , caused a noticeable, but less marked MSR increase (Fig. 1 B) . To exclude effects due to growth factor-induced proliferation, loading of lysates per well was corrected for total cellular protein concentration. In addition, it has previously been shown that M-CSF treatment of human monocyte-derived M(3 increases cell size rather than cell number (2) . The observed increase in MSR protein would therefore be even more significant at a single cell level. Conditioned media from mouse L cells (a rich source of murine M-CSF [13] ) or insect cells transfected with murine M-CSF eDNA similarly increased MSR expression, and this effect was abrogated by the addition of species-specific antibodies to M-CSF (data not shown). The increase in MSK expression was dose dependent and plateaued at concentrations of 500-1,000 U/ml M-CSF (data not shown).
Immunoprecipitation of MSR from metabolically labeled cells confirmed the upregulation by M-cAr (Fig. 2) . The mAb 2F8 detects both type I and II isoforms of the MSK (11) and the MSR is seen in its reduced monomeric form. M-CSF increased MSK protein synthesis 2.3-fold (Phosphorlmager quantification) even after 48 h of treatment, as is evident from the 0-h chase point after a 30-min labeling period. The more impressive increases seen at 12 (4.5-fold) and 36 h (6-fold) signify that, in addition to increasing MSR synthesis, M-CSF also markedly prolonged the half-life of synthesized receptor.
Expression of MSR at a single cell level as determined by flow cytometry ( Table 1 A) confirmed that M-CSF upregulated MO cell surface expression of the receptor. The greater than twofold increase in MSR surface expression was not parallded by the more modest 18% increase seen when intracellular (internal) levels of antigen were assessed by permeabilizing the cells with saponin. It was therefore possible that M-CSF may have redistributed the substantial intracdlular pool of MSR to the cell surface. Indirect immunofluorescence studies with the mAb 2F8, although difficult to quantify, supported this hypothesis (data not shown). It is interesting to note that GM-CSF had little effect on surface or internal MSR expression as assessed by flow cytometry, in keeping with the slight increase seen by immunoblotting.
The possible redistributive effect of M-CSF was investigated by biochemically quantifying the fraction of total MSR on the cell surface at steady state (Table 1 B) . Cells were metabolically labeled to equilibrium foUowed by surface biotinylation, on ice, by the membrane-impermeant probe sulfo-NHS-SS-biotin (14) . After cell lysis, total MSR was precipitated by mAb 2F8 and the resulting immunoprecipitate divided into two equal aliquots. Biotinylated "surface" MSR was precipitated from one aliquot using streptavidin-agarose and "total" MSR was precipitated from the other aliquot by a second round of mAb 2F8 immunoprecipitation. Total and biotinylated MSR were quantitated after SDS-PAGE by Phosphorlmager analysis of dried gels. In these experiments M-CSF increased surface MSR expression 13-fold and total MSR protein synthesis nearly 5-fold relative to untreated controls. In addition, M-CSF treatment was associated with a shift of the cellular pool of MSR from a mainly intraceUular location (69% of total) to a predominantly surface distribution (82% of total).
To exclude the possibility that the M-CSF effect on MSR expression represented a nonselective epiphenomenon of MO differentiation, we analyzed the action of M-CSF on several other MO integral membrane proteins (Table 1 B) . The ex- Figure 2 . M-CSF increases MSR protein synthesis. BgPM~) were treated in vitro for 48 h with human M-CSF (1,000 U/ml), metabolically labeled with Tran3SS-label TM and chased for the indicated periods. Pr~pitates were adjusted to represent equivalent total protein concentrations, and separated by SDS-PAGE in the presence of B-ME. MSR precursor and monomer migrate at ~ and 90 Fa:l, respectively. Gels were fixed, impregnated with EN3HANCE, dried, and exposed to film at -70~ ( ' ) Molecular weight standards in kilodaltons. pression of surface and internal pools of F4/80 (a M~-specific differentiation antigen), type 3 complement receptor, MHC class II antigen and macrosialin (a M~-speciiic late endosomal membrane molecule) were analyzed by flow cytometry. M-CSF treatment elicited slight increases only in surface CR3 (15%) and internal F4/80 (6%) levels. The other antigens were either unchanged or decreased. Immnnoblots of M-CSF treated BgPM~ also showed no alteration in expression of MMR or class II MHC (data not shown). These results point to a selective effect of M-CSF on MSR expression in an elicited primary M~ population.
The point at which M-CSF mediates its upregulatory effect was investigated by semi-quantitative RT-PCR to detect MSR mRNA changes in response to M-CSF (Fig. 3) . This assay provides a sensitive measure of mRNA in M(3, and control serial dilution experiments confirmed that for each set of primers the level of detection could be related to the initial cellular input used to prepare the cDNA. Two isoforms of MSR arise from alternative splicing of transcripts derived from a single gene. Both isoforms have been detected in atherosclerotic lesions and bind MSR ligands with equal affinities (18, 19) . After M-CSF treatment for 48 h, there was a substantial increase in MSR mRNA (MSR-C). In addition, levels of mRNA specific for both type I and II MSR mRNA were increased, excluding a type-selective effect for M-CSE Although type I MSR mRNA was present in untreated cells, type II MSR protein is more prevalent in vivo and in vitro (15) . Detection of type I message in the control cells could, however, be explained by increased annealing affinity of the specific set of primers for the cDNA template. Similar results were obtained after 24 h of M-CSF incubation (data not shown). M-CSF therefore also upregulates MSR expression at mRNA level. Whether this is due to transcriptional upregulation or posttranscriptional stabilization was not addressed.
As described, M-CSF increased MSR expression at several different levels: message, protein synthesis, protein stability, and shift of mature protein to the cell surface. The significance of these observed differences was tested by relating them to functional MSR studies. Traditionally, the MSR has been characterized as an endocytic receptor (20) with a broad ligandbinding specificity for a range of polyanions (including modified lipoproteins). The ability of treated BgPMt~ to endocytose and accumulate fluorescent AcLDL (DiI-AcLDL) was therefore tested (Table 2) . M-CSF-mediated upregulation of routine MSR was associated with an enhanced capacity (1.7-3-fold) of treated M~ to endocytose AcLDL. AcLDL uptake is regarded as a specific marker for MSR function, as the thrombospondin receptor (CD36) and the Mt~ receptor for the Fc region of IgG (Fc3~RII-B2; CD32) may mediate uptake of oxidized but not acetylated lipoprotein (6, 7) .
A recently described novel function for the MSR is divalent cation-independent adhesion (11) . The ability of M-CSFtreated BgPM(3 to adhere to serum-treated TCP in an EDTAindependent manner was investigated. M-CSF increased adhesion at 60 min by 63% and at 90 min by 96%; this effect was completely abolished in the presence of mAb 2F8 (data not shown). The adherence of M-CSF-treated M~ in vitro was therefore markedly increased in a MSR-dependent (divalent cation-independent, 2F8-inhibitable) fashion.
Atherogenesis is characterized by both the proliferation of smooth muscle cells, M~, and lymphocytes in the artery wall and the accumulation of cholesterol and cholesteryl esters in the surrounding connective tissue matrix and associated cells. Besides acting as a growth factor for the proliferation and differentiation of monocytic progenitors, M-CSF is also required for the survival and activation of mature monocytes and M~ (21) . The LDL receptor is primarily responsible for regulating plasma LDL homeostasis and LDL-cholesterol delivery to tissue and cells by clearing plasma-derived LDLcholesterol. Hepatic LDL receptor function, as assayed by LDL binding, is however not markedly affected by M-CSF treatment. GM-CSF had a minimal effect on MSR activity and its cholesterol lowering effect could be mediated indirectly through stimulation of TNF and/or IL-1 secretion (22) . In contrast, our evidence shows that M-CSF significantly enhances MSR expression and function in vitro. This provides a mechanism whereby production of M-CSF in the atheromatous plaque microenvironment could enhance the recruitment and retention of mononuclear phagocytes and subsequent accumulation of cholesteryl esters and foam cell formation. BgPMO were treated for 48 h with human M-CSF and MSR-mediated uptake of DilAcLDL measured as described (11, 16) . Specific fluorescent intensity was calculated by subtracting autofluorescent intensity from fluorescent intensity of DiIAcLDL-labeled cells using geometric means derived from data analysis by Lysys II software (Bee'ton Dickinson). Results show the mean values _+ standard deviation (three independent experiments in triplicate).
